Joyzyme Group Stock

Joyzyme Group Debt

The Debt of Joyzyme Group (8622.HK) as of Aug 11, 2026 is -42.76 M CNY. In the previous year, Debt was -30.32 M CNY — a change of 41.04% (lower).

Debt

-42.76 MCNY

YoY

41.04%

Last updated:

In 2026, Joyzyme Group's total debt was -42.76 M CNY, a 41.04% change from the -30.32 M CNY total debt recorded in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Joyzyme Group Stock analysis

What does Joyzyme Group do? Huakang Biomedical Holdings Co Ltd is a leading company in the field of biomedical research and development. It was founded in 2004 and is headquartered in Shenzhen, China. The company is listed on the Hong Kong Stock Exchange (HKEX: 8622) and has branches in various countries, including Germany and the USA. Answer: Huakang Biomedical Holdings Co Ltd is a leading company in the field of biomedical research and development. It was founded in 2004 and is headquartered in Shenzhen, China. The company is listed on the Hong Kong Stock Exchange (HKEX: 8622) and has branches in various countries, including Germany and the USA. Joyzyme Group is one of the most popular companies on Eulerpool.

Debt Details

Understanding Joyzyme Group's Debt Structure

Joyzyme Group's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Joyzyme Group's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Joyzyme Group’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Joyzyme Group’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Joyzyme Group stock

Debt of Joyzyme Group is -42.76 M CNY in 2026.

Debt of Joyzyme Group changed from -30.32 M CNY to -42.76 M CNY, representing a 41.04% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Joyzyme Group since 2006 – with annual values, charts, and detailed analysis.

Debt's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Joyzyme Group historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Joyzyme Group

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Joyzyme Group